AU2012315083B2 - Amino acid sequences for controlling pathogens - Google Patents

Amino acid sequences for controlling pathogens Download PDF

Info

Publication number
AU2012315083B2
AU2012315083B2 AU2012315083A AU2012315083A AU2012315083B2 AU 2012315083 B2 AU2012315083 B2 AU 2012315083B2 AU 2012315083 A AU2012315083 A AU 2012315083A AU 2012315083 A AU2012315083 A AU 2012315083A AU 2012315083 B2 AU2012315083 B2 AU 2012315083B2
Authority
AU
Australia
Prior art keywords
seq
peptide
group
oreochromicin
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012315083A
Other languages
English (en)
Other versions
AU2012315083A1 (en
Inventor
Jannel Acosta Alba
Mario Pablo Estrada Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centro de Ingenieria Genetica y Biotecnologia CIGB
Original Assignee
Centro de Ingenieria Genetica y Biotecnologia CIGB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB
Publication of AU2012315083A1 publication Critical patent/AU2012315083A1/en
Application granted granted Critical
Publication of AU2012315083B2 publication Critical patent/AU2012315083B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2012315083A 2011-09-30 2012-10-01 Amino acid sequences for controlling pathogens Ceased AU2012315083B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2011-0181 2011-09-30
CU20110181A CU24076B1 (es) 2011-09-30 2011-09-30 Composición para el control de patógenos
PCT/CU2012/000005 WO2013044890A1 (es) 2011-09-30 2012-10-01 Secuencias de aminoácidos para el control de patógenos

Publications (2)

Publication Number Publication Date
AU2012315083A1 AU2012315083A1 (en) 2014-05-08
AU2012315083B2 true AU2012315083B2 (en) 2016-02-25

Family

ID=47143463

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012315083A Ceased AU2012315083B2 (en) 2011-09-30 2012-10-01 Amino acid sequences for controlling pathogens

Country Status (16)

Country Link
US (1) US9549978B2 (https=)
EP (1) EP2767290B1 (https=)
JP (1) JP6034385B2 (https=)
KR (1) KR101986358B1 (https=)
CN (1) CN103874502B (https=)
AR (1) AR088176A1 (https=)
AU (1) AU2012315083B2 (https=)
BR (1) BR112014007491B1 (https=)
CA (1) CA2849040C (https=)
CL (1) CL2014000760A1 (https=)
CU (1) CU24076B1 (https=)
ES (1) ES2600903T3 (https=)
MX (1) MX348934B (https=)
RU (1) RU2636001C2 (https=)
WO (1) WO2013044890A1 (https=)
ZA (1) ZA201402171B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104262485B (zh) * 2014-04-15 2017-01-18 四川农业大学 罗非鱼sIgM截短重链恒定区蛋白多克隆抗体及其制备方法
CN105061575B (zh) * 2015-02-03 2020-08-04 浙江海洋学院 一种金枪鱼肝脏抗菌肽及其制备方法和用途
CN109350731A (zh) * 2018-12-18 2019-02-19 汕尾市维明生物科技股份有限公司 一种罗非鱼蛋白肽在制备免疫制剂中的应用
CN112979763A (zh) * 2021-03-03 2021-06-18 山东大学 一种基于可溶性疏水载体抗菌肽Oreoch-2的液相合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200825098A (en) * 2006-12-05 2008-06-16 Academia Sinica Anti-microbal peptides and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030056244A1 (en) * 2000-05-02 2003-03-20 Ning Huang Feed additive compositions and methods
US6753407B2 (en) * 2000-08-15 2004-06-22 North Carolina State University Antimicrobial peptides isolated from fish
WO2002014346A2 (en) * 2000-08-15 2002-02-21 North Carolina State University Antimicrobial peptides isolated from fish
CN1678632A (zh) * 2002-08-22 2005-10-05 加拿大国家研究所 一种从硬骨鱼中鉴定新的广谱抗菌肽的基因组途径
CN101111256B (zh) * 2004-12-15 2012-04-25 科罗拉多大学 抗菌肽及其使用方法
RU2302467C1 (ru) * 2005-12-01 2007-07-10 Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук Пептиды латарцины, проявляющие антимикробную активность
CA2645832A1 (en) * 2006-04-25 2007-11-01 Intercell Ag Hcv vaccinations
WO2009149554A1 (en) * 2008-06-11 2009-12-17 National Research Council Of Canada Antimicrobial components of the mucus and extruded slime of hagfish (myxine glutinosa)
CN102348723A (zh) * 2008-12-05 2012-02-08 安吉奥开米公司 肽治疗剂轭合物及其应用
US20100184684A1 (en) * 2009-01-06 2010-07-22 C3 Jian, Inc. Antibacterial and antifungal peptides
WO2010091294A2 (en) * 2009-02-05 2010-08-12 The Regents Of The University Of California New targeted antimicrobial moieties
CN101559214A (zh) * 2009-05-27 2009-10-21 珍奥集团股份有限公司 具有增强免疫功能作用的组合物及其用途
CN102021172A (zh) * 2010-06-23 2011-04-20 广西壮族自治区水产研究所 罗非鱼白细胞 cAMP 诱导早期抑制因子基因序列及用途
US9155800B2 (en) * 2011-01-07 2015-10-13 Valiant Biopharma Sdn Bhd Antimicrobial fusion compounds and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200825098A (en) * 2006-12-05 2008-06-16 Academia Sinica Anti-microbal peptides and uses thereof

Also Published As

Publication number Publication date
US9549978B2 (en) 2017-01-24
CN103874502B (zh) 2015-11-25
ZA201402171B (en) 2015-12-23
BR112014007491A2 (pt) 2017-04-04
MX2014003892A (es) 2014-07-09
CU24076B1 (es) 2015-01-29
EP2767290B1 (en) 2016-09-14
BR112014007491B1 (pt) 2022-03-03
CU20110181A7 (es) 2013-05-31
ES2600903T3 (es) 2017-02-13
JP2014533931A (ja) 2014-12-18
AU2012315083A1 (en) 2014-05-08
AR088176A1 (es) 2014-05-14
WO2013044890A1 (es) 2013-04-04
RU2014117659A (ru) 2015-11-10
CN103874502A (zh) 2014-06-18
JP6034385B2 (ja) 2016-11-30
KR20140070597A (ko) 2014-06-10
CA2849040A1 (en) 2013-04-04
KR101986358B1 (ko) 2019-06-05
MX348934B (es) 2017-07-03
US20140294871A1 (en) 2014-10-02
RU2636001C2 (ru) 2017-11-17
EP2767290A1 (en) 2014-08-20
CL2014000760A1 (es) 2014-08-22
CA2849040C (en) 2019-11-26

Similar Documents

Publication Publication Date Title
Klüver et al. Synthesis and structure–activity relationship of β‐defensins, multi‐functional peptides of the immune system
Wang et al. Functions of antimicrobial peptides in gut homeostasis
US20210246177A1 (en) Cath2 derivatives
US11186619B2 (en) Antimicrobial peptides based on CMAP27
RU2646137C2 (ru) КОМПОЗИЦИЯ ПО ПРЕДУПРЕЖДЕНИЮ ИНФЕКЦИИ Mycoplasma spp.
AU2012315083B2 (en) Amino acid sequences for controlling pathogens
Li et al. Antimicrobial peptides: sources, expression systems, and applications
KR100854594B1 (ko) 톨-유사 수용체-5 자극 활성이 강화된 ｐａｓ-플라젤린융합 단백질
KR101286733B1 (ko) 세포표면에서 발현되는 항균 펩타이드 다중합체
CA2873599A1 (en) Peptides inducing an immune response against copepods and/or the development of a mucous shield in fish; vaccines, uses and methods for modulating the fish immune response and/or for inducing development of a mucous shield in fish
JP6921387B2 (ja) 抗微生物ポリペプチド
US12246045B2 (en) Method for preparing a transformed, Salmo salar interferon gamma (IFNG)-producing Lactococcus lactis bacterium
Blumhardt Antimicrobial peptides: immunomodulatory and therapeutic potential for use in Atlantic salmon (Salmo salar)
Li et al. Chemical aspects of the preservation and safety control of sea foods
Shen et al. Structure, biological properties and utilities of marine-derived antimicrobial peptides
Chanu et al. Structure-activity relationship of buffalo antibacterial hepcidin analogs
US20240010690A1 (en) Oral vaccine, method of preparation and use thereof
Kannaki et al. Antimicrobial activity of recombinant E. coli expressed chicken AvBD-2 and its mRNA expression in Indian native Aseel and Kadaknath chicken breeds.
AU2012241592A1 (en) Combination vaccine

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)